Study S002294

Effect of GLP-1 Receptors Agonist Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02274740
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: TERMINATED
Enrollment: 2
Start: 2015-04
Primary completion: 2015-08
Lead sponsor: Sanofi
Conditions: Type II Diabetes Mellitus
Interventions: DRUG:LIXISENATIDE AVE0010; DRUG:metformin
Results posted: FALSE
Secondary identifiers: OTHER:U1111-1153-3774

Registered primary outcomes

Change in plasma triglycerides after 10 weeks of treatment area under-the-time concentration curve between 0 and 480 minutes (AUC0-480 min) [After 10 weeks of treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.